expected weight loss with tirzepatide vs Semaglutide: Which is more effective in the real world? Average weight loss and results

Patients should carry documentation of their prescription and consider bringing extra supplies when feasible

Starting with CJC-1295/Ipamorelin, transitioning to sermorelin for maintenance: A patient uses CJC/Ipa to achieve target body composition and IGF-1 levels, then steps down to sermorelin for long-term maintenance with a lighter protocol

In clinical trials, individuals using tirzepatide for weight loss have seen an average weight reduction of 15% to 21% of their starting body weight over approximately 72 weeks

You have a 10 mg vial reconstituted with 1 mL of water, giving you a 10 mg/mL concentration

Severe adverse effects (requiring study discontinuation) were reported in 6.7% of cases and 3.0% of controls